Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DD-transpeptidase is a bacterial enzyme essential for peptidoglycan biosynthesis, catalyzing the cross-linking of peptide side chains in the bacterial cell wall. It is a target for β-lactam antibiotics, which inhibit its activity and disrupt cell wall synthesis, leading to bacterial cell death or stasis.
β-lactam antibiotics irreversibly acylate the active site serine residue, blocking enzymatic activity required for cell wall synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DD-Transpeptidase.